arrow
J

Jonathan D. Schoenfeld

Mass General Brigham
H指数:44
被引数:8,072

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An agentic AI system enhances clinical detection of immune-related adverse events in a multi-phase validation study

agentic AI系统可在多阶段验证研究中增强免疫相关不良事件的临床检测

2026-10-290
OAAI
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial

人乳头瘤病毒(HPV)循环肿瘤DNA指导下的风险适应性疗法在HPV阳性口咽癌中的探索性II期试验(ReACT 1.0)

2026-05-070
OAAI
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer

PTPN2抑制在头颈鳞状细胞癌中释放对STING激动剂的反应

2026-05-020
OAAI
Integrated Multidisciplinary Care Reduces Time to Treatment in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Retrospective Cohort Study

整合多学科护理可缩短晚期皮肤鳞状细胞癌患者接受治疗的时间:一项回顾性队列研究

2026-04-020
PRE
Less of Some and More of Another: Practice-changing Head and Neck Trials Are Redefining Long-standing Treatment Paradigms and Offering Patients More Risk-adapted Care

“少一些,多一些”:改变实践的头颈临床试验正在重新定义长期存在的治疗模式,并为患者提供更多风险适应性的护理。

2025-11-170
PRE
Adjuvant radiation is associated with reduced risks of local recurrence and nodal metastasis in high-risk localized cutaneous squamous cell carcinoma: a retrospective multicenter cohort study

辅助放疗与高危局限性皮肤鳞状细胞癌局部复发和淋巴结转移风险降低相关:一项回顾性多中心队列研究

2025-10-220
PRE
Chemosensitization is not associated with improved adjuvant radiation outcomes for cutaneous squamous cell carcinoma: a dual-center retrospective cohort study

化学增敏与皮肤鳞状细胞癌辅助放疗结果的改善无关:一项双中心回顾性队列研究

2025-09-110
PRE
Stereotactic magnetic resonance imaging-guided adaptive radiotherapy: a pooled analysis of a master prospective trial

立体定向磁共振成像引导自适应放射治疗:一项主前瞻性试验的合并分析

2025-09-010
PRE
A PHASE 1/2 STUDY ASSESSING SAFETY AND PHARMACOKINETICS OF CEMIPLIMAB IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID OR CENTRAL-NERVOUS-SYSTEM TUMORS AND SAFETY AND EFFICACY OF CEMIPLIMAB IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA, NEWLY DIAGNOSED HIGH-GRADE GLIOMA, OR RECURRENT HIGH-GRADE GLIOMA
2024-06-180
OAAI